Skip to main content

Table 2 Continuous variable of patients with or without UFUR maintenance for ypstage III rectal cancer

From: Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study

Variable

with UFUR maintenance

Median (Range)

without UFUR maintenance

Median (Range)

P value

Age

64.7 (35–86)

68.0 (13–83)

0.185

BMI

24.1 (16.3–31.9)

24.2 (13.2–34.0)

0.675

CEA, ng/mL

4.8 (0.5–116.5)

4.0 (0.4–53.13)

0.212

ELN

14 (4–43)

21 (3–51)

0.029

LNR

0.21 (0.03–0.92)

0.20 (0.02–0.84)

0.782

Tumorlocation, cm

6.63 (1–12)

7.42 (3–12)

0.254

Follow-up (month)

64.0 (19.0–124.0)

73.1 (15.4–148.3)

0.207

  1. UFUR tegafur-uracil, BMI body mass index, CEA carcinoembryonic antigen, ELN total examined nodes number, LNR the ratio of metastatic lymph nodes to the total examined nodes number